FIELD: medicine.
SUBSTANCE: invention refers to an agent for activation of lipoprotein lipase containing a benzene derivative of general formula 
(1) which is used for preventing and treating hyperlipidemia and obesity. The invention also refers to the benzene derivatives of general formula 
(1a).
EFFECT: composition improvement.
8 cl, 6 tbl, 9 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHENYLIMIDAZOLE COMPOUNDS | 2010 |
|
RU2497811C2 |
| OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION | 2006 |
|
RU2418793C2 |
| COMPOUNDS OF 3-SUBSTITUTED 1-ARYLINDOLE AND PHARMACEUTICAL COMPOSITION BASED ON SAID | 1994 |
|
RU2139287C1 |
| NITROIMIDAZOOXAZINE AND NITROIMIDAZOOXAZOLE ANALOGUES AND USE THEREOF | 2010 |
|
RU2540860C2 |
| DERIVATIVES OF CARBAPENEM, THEIR USING FOR PREPARING PHARMACEUTICAL COMPOSITION, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD FOR TREATMENT AND/OR PROPHYLAXIS OF INFECTIOUS DISEASES | 2001 |
|
RU2276154C2 |
| QUINOLINE AND QUINAZOLINE DERIVATIVES WITH AFFINITY TO 5HT-RECEPTORS | 2004 |
|
RU2402533C2 |
| CONDENSED TRICYCLIC DERIVATIVES FOR TREATING PSYCHOTIC DISORDERS | 2005 |
|
RU2409582C2 |
| USING EP4 RECEPTOR LIGANDS IN TREATMENT OF IL-6-MEDIATED DISEASES | 2003 |
|
RU2285527C2 |
| GUANIDINE DERIVATIVES, METHOD OF PREPARATION THEREOF, AND METHOD FOR INHIBITING Na/H EXCHANGE IN CELLS | 1994 |
|
RU2141946C1 |
| NOVEL IMIDAZOOXAZINE COMPOUND OR SALT THEREOF | 2012 |
|
RU2578608C2 |
